Powered by
-
BMY Stock Chart
Historical BMY Prices
Bristol-Myers Squibb Stock Analysis
Rating: Sell
Total Grade: D
Analysis Breakdown
| BMY Stock Grade: | D |
| Fundamental Grade: | C |
| Quantitative Grade: | D |
| BMY Earnings | |
| Earnings Growth: | F |
| Earnings Momentum: | A |
| Earnings Surprises: | B |
| Analyst Earnings Revisions: | B |
| BMY Financial Information | |
| Sales Growth: | C |
| Operating Margin Growth: | F |
| Cash Flow: | C |
| Return on Equity: | C |
Bristol-Myers Squibb Stock: Weekly View
| This Week: | D |
|---|---|
| Last Week: | C |
| Two Weeks Ago: | C |
BMY Stock predictions, Articles, and Bristol-Myers Squibb News
- From InvestorPlace
- From the Web
-
Why Bristol-Myers Squibb Is a Great Dividend Stock - September 5, 2018
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Bristol-Myers Squibb (BMY) have what it.... Continue…
-
5 Top Stocks to Challenge a Notorious September - September 4, 2018
Among the two pillars of the U.S. economy, consumer confidence is strong and corporate earnings continue to grow. Compare Brokers.... Continue…
-
Heat Biologics Stock Is a Worthwhile, Speculative Bet - August 15, 2018
Heat Biologics has a partnership with Bristol-Myers in developing a cancer drug. If things continue to progress positively, HTBX stock could climb higher. Continue…
-
5 Big Pharma Stocks Investors Love Right Now - July 13, 2018
The biotechnology and pharmaceutical sectors continue to offer great value for investors, and these five Big Pharma stocks stand out from the crowd. Continue…
-
Why Bristol-Myers Squibb Company Shares Are Down Today - June 4, 2018
Bristol-Myers Squibb Company (BMY) shares were sliding as the company's collaboration cancer drug with Nektar Therapeutics (NKTR) did not impress investors. Continue…
-
Why Nektar Therapeutics Shares Are Plunging Today - June 4, 2018
Nektar Therapeutics (NKTR) took a heavy hit on Monday following the release of preliminary results from a recent clinical trial. Continue…
-
Pfizer Inc. Stock Is Boring But Great for Your Portfolio’s Health - May 1, 2018
Fundamentally PFE is too cheap. So go long on this earnings dip inside a nervous market. Management is proven for decades and is bankable for the future. Continue…
-
Bristol-Myers Squibb Co Reports Earnings for First Quarter of 2018 - April 26, 2018
Bristol-Myers Squibb (BMY) released its earnings report for the first quarter of the year of Thursday and it was a mixed bag. Continue…
-
Stocks Push Forward As Fears of War Diminish - April 17, 2018
Stocks climbed again on Monday, shrugging off the U.S.-led airstrike on Syria over the weekend. Now the market will get an update on U.S. industrial production as well as a batch of Federal Reserve policymaker speeches. Continue…
-
5 Trades to Make First Thing Tomorrow Morning - April 16, 2018
On Monday we had be big moves from Bank of America, Starbucks, Ford and others. Here's 5 hot stocks to watch and what trades to make on Tuesday. Continue…
